Skip to Main Content

Switching to Potential Reduced Exposure Products in Adult Smokers (JUUL)

Conditions

Addictive Behaviors | Mental Health & Behavioral Research | Tobacco Addiction

What is the purpose of this trial?

Brief Summary:

This study aims to assess the feasibility, acceptability, and the potential harm reduction of switching to potentially lower risk, non-combustible tobacco products in adult smokers. Part One of this study aims to assess the interest of current smokers in switching to an e-cigarette device (i.e. JUUL) compared to alternative non-combustible tobacco products (i.e. smokeless tobacco/snus) and/or medicinal nicotine via survey. Part Two will consist of a pilot study of 50 non-treatment seeking adult smokers with medical co-morbidities to investigate within-person changes in smoking behavior as a result of switching to different concentrations a nicotine salt electronic cigarette product (i.e. JUUL, 3% and 5% nicotine concentration). Additionally, by measuring bio-markers of tobacco exposure from baseline, this will allow the study to assess the potential for harm reduction in switching from cigarettes to an e-cigarette device.

  • Trial with
    National Institute on Drug Abuse (NIDA)
  • Start Date
    12/09/2018
  • End Date
    01/30/2021
Trial Image

For more information about this study, contact:

Lisa Fucito

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    05/12/2020
  • Study HIC
    #2000023826